Assessing the Effectiveness of Valbenazine in the Treatment of Tardive Dyskinesia as Determined by the AIMS and PGIC: Results from the KINECT 4 Trial

被引：0
|
作者：
Singer, C.
Comella, C.
Farahmand, K.
Burke, J.
Jimenez, R.
Siegert, S.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
70
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [11] Efficacy of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia: Results of a Long-Term Study (KINECT 3 Extension)
    Factor, Stewart
    Comella, Cynthia
    Correll, Christoph
    Liang, Grace
    Burke, Joshua
    O'Brien, Christopher
    NEUROLOGY, 2017, 88
  • [12] Trajectories of Tardive Dyskinesia Impact Scale (TDIS) and Abnormal Involuntary Movement Scale (AIMS) Over Time with Valbenazine Treatment
    Perez-Rodriguez, M.
    Stull, D.
    Dhanda, R.
    Bron, M.
    Dunayevich, E.
    Correll, C.
    MOVEMENT DISORDERS, 2023, 38 : S294 - S295
  • [13] VALBENAZINE (NBI-98854) FOR THE TREATMENT OF TARDIVE DYSKINESIA: ANALYSIS BY UNDERLYING PSYCHIATRIC DIAGNOSIS IN PHASE III KINECT 3 STUDY
    Josiassen, Richard
    Kane, John
    Burke, Joshua
    Jimenez, Roland
    Siegert, Scott
    Liang, Grace
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S217 - S217
  • [14] EFFICACY AND SAFETY OF VALBENAZINE (NBI-98854) IN SUBJECTS WITH TARDIVE DYSKINESIA: RESULTS OF A LONG-TERM STUDY (KINECT 3 EXTENSION)
    Siegert, S.
    Factor, S.
    Liang, G.
    Burke, J.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E35 - E35
  • [15] Efficacy of Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia: Results of a Long-Term Extension Study (KINECT 3 Extension)
    Grigoriadis, Dimitri
    Comella, Cynthia
    Remington, Gary
    Jimenez, Roland
    Burke, Joshua
    Christopher, O'Brien
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S213 - S214
  • [16] Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia (vol 24, pg 103, 2020)
    Ganz, M. L.
    Chavan, A.
    Dhanda, R.
    Serbin, M.
    Yonan, C.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1108 - 1108
  • [17] EFFECTS OF LONG-TERM VALBENAZINE IN KINECT 4: POST HOC RESPONSE AND SHIFT ANALYSES IN YOUNGER AND OLDER ADULTS WITH TARDIVE DYSKINESIA
    Sajatovic, Martha
    Alexopoulos, George
    Farahmand, Khodayar
    Jimenez, Roland
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : S145 - S146
  • [18] KINECT 3: A randomized, double-blind, placebo-controlled phase 3 trial of valbenazine (NBI-98854) for tardive dyskinesia
    Factor, S. A.
    Hauser, R. A.
    Siegert, S.
    Liang, G. S.
    O'Brien, C. F.
    MOVEMENT DISORDERS, 2016, 31 : S692 - S692
  • [19] KINECT 3: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Valbenazine (NBI-98854) for Tardive Dyskinesia
    Hauser, Robert
    Factor, Stewart
    Marder, Stephen
    Knesevich, Mary Ann
    Ramirez, Paul Michael
    Jimenez, Roland
    Burke, Joshua
    Liang, Grace
    O'Brien, Christopher
    NEUROLOGY, 2016, 86
  • [20] SAFETY RESULTS FROM 3 LONG-TERM VALBENAZINE STUDIES IN YOUNGER AND OLDER ADULTS WITH TARDIVE DYSKINESIA
    Alexopoulos, George
    Sajatovic, Martha
    Alrais, Mena
    Burke, Joshua
    Farahmand, Khodayar
    Siegert, Scott
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S176 - S176
12345